US 11649261
Crystalline forms of a CD73 inhibitor and uses thereof
granted A61KA61K31/706A61K45/06
Quick answer
US patent 11649261 (Crystalline forms of a CD73 inhibitor and uses thereof) held by Arcus Biosciences, Inc. expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcus Biosciences, Inc.
- Grant date
- Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/706, A61K45/06, A61P, A61P35/00